+7 495 640-17-71



Important news

“DNA-Technology” has completed the quality assessment study of SARS-CoV-2 molecular detection coordinated by Quality Control for Molecular Diagnostics (QCMD), UK. The Panel  Composition included Alpha, Beta SARS-CoV-2 Variants, etc. The correct result was obtained in 100% of cases.


First outbreak of the Candida auris, type of yeast or fungi, has been reported recently in the Texas and Washington, USA (source). This fungus is not dangerous for the people with strong immune system, but can be a big problem for those with the impaired immunity – people with chronic or opportunistic diseases.


“DNA-Technology” has completed the quality assessment study of SARS-CoV-2 molecular detection coordinated by Quality Control for Molecular Diagnostics (QCMD), UK. As the only Russian participant, “DNA-Technology” entered the target group and received an International Certificate confirming the quality of products: during quality assessment study a complete technological process chain was tested, including equipment and kits for RNA extraction and SARS-CoV-2 detection. The correct result was obtained in 100% of cases. Read the QCMD report.


All news

We are pleased to invite you in our stand 3E57, hall 3 to explore innovations of PCR technology. Reserve a time slot sending request to info@dna-technology.com
We are looking forward to meeting you!


We are pleased to announce the publication of the ORIGINAL RESEARCH in BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (Bulletin of RSMU; Moscow, Russia) - Microbiota of semen  samples with normozoospermia: analysis of real-time PCR data; Voroshilina ES, Zornikov DL, Ivanov AV, Pochernikov DG, Panacheva EA.



Experts from the World Health Organization have checked the quality of PCR analysis performed by the Biomedica laboratory (the Company's partner in Georgia). Reagents kits for the detection of SARS-CoV-2 manufactured by DNA-Technology received the highest rating as the most accurate test system. The report can be found here


Our company has received a confirmation of the fulfillment of applicable requirements of the European Council Directive 98/79/EC and now officially holds the right to affix CE marking on the following products:


We are pleased to announce the launch of our new AVRI Panel Multiplex PCR kit.  The kit can be used in the research practice and does not depend on population and demographic aspects. More information about the kit is available on the product page


New research that was aimed to investigate molecular basis of the vaginal microbiome applying the Femoflor® 16 test system in women with nonspecific colpitis has become available on the website under Study Guides section. As a result of the extensive research, authors have confirmed that the real-time PCR-based Femoflor® 16 test system provides results corresponding to those of conventional microbiology regarding the assessment of the vaginal flora state. For more information on the research summary report click here.


In this publication we offer to review the results of a study conducted under the guidance of Professor Ekaterina Voroshilina, Doctor of Medical Sciences, presented during the international conference ESHRE ’s 37th virtual Annual Meeting 2021 (European Society for Human Reproduction and Embryology).


Dear partners,

“DNA-Technology” will be closed for public holidays from May 1 to May 10, 2021. We will resume our regular work on the May 11. Please, consider this information for your workflow plans.


We are pleased to present a new article "Differential Expression of Local Immune Response Genes in the Vagina: Implication for the Diagnosis of Vaginal Infections" by A. M. Savicheva with a group of authors from D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology and St. Petersburg State Pediatric Medical University, St. Petersburg.